Published in Thromb Haemost on April 04, 2012
Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure. PLoS One (2013) 0.82
Plasma clot lysis time and its association with cardiovascular risk factors in black Africans. PLoS One (2012) 0.78
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk. Cardiovasc Diabetol (2017) 0.75
Objective method of assessing and presenting the House-Brackmann and regional grades of facial palsy by production of a facogram. Otol Neurotol (2010) 1.53
Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost (2011) 1.52
Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study. Diabetes Care (2003) 1.40
In vivo roles of factor XII. Blood (2012) 1.37
Metagenomic sequencing reveals microbiota and its functional potential associated with periodontal disease. Sci Rep (2013) 1.30
Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma (2007) 1.15
A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res (2009) 1.14
Improved screening for silent atrial fibrillation after ischaemic stroke. Europace (2012) 1.03
Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans. Arterioscler Thromb Vasc Biol (2010) 1.03
Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ (2013) 0.96
Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers. J Neurotrauma (2007) 0.95
Light-induced helix formation. J Am Chem Soc (2002) 0.93
Desktop nanofabrication with massively multiplexed beam pen lithography. Nat Commun (2013) 0.91
Study on two operating conditions of a full-scale oxidation ditch for optimization of energy consumption and effluent quality by using CFD model. Water Res (2011) 0.90
Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin. Arterioscler Thromb Vasc Biol (2006) 0.89
Marked increase of fibrin gel permeability with very low dose ASA treatment. Thromb Res (2005) 0.88
Techniques used to study transcription on chromatin templates. Methods Enzymol (2004) 0.87
Positionally defined, binary semiconductor nanoparticles synthesized by scanning probe block copolymer lithography. Nano Lett (2012) 0.85
A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma. Thromb Haemost (2007) 0.84
Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate. Br J Haematol (2011) 0.84
Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations? Clin Chem Lab Med (2008) 0.84
Changes in von Willebrand factor and ADAMTS13 during IVF. Blood Coagul Fibrinolysis (2011) 0.84
Thrombin generation in acute cardioembolic and non-cardioembolic ischemic stroke. Scand J Clin Lab Invest (2013) 0.83
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. Thromb Res (2007) 0.83
Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light. Transfusion (2003) 0.83
Platelet-derived microparticles during and after acute coronary syndrome. Thromb Haemost (2012) 0.83
Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke. Blood Coagul Fibrinolysis (2007) 0.83
Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials. Blood Coagul Fibrinolysis (2005) 0.82
In vitro studies using a global hemostasis assay to examine the anticoagulation effects in plasma by the direct thrombin inhibitors: dabigatran and argatroban. J Thromb Thrombolysis (2013) 0.82
Hormonal regulation of circulating C-reactive protein in men. Clin Chem (2005) 0.82
Locally altering the electronic properties of graphene by nanoscopically doping it with Rhodamine 6G. Nano Lett (2013) 0.81
Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA. Platelets (2013) 0.81
The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis. Thromb Haemost (2010) 0.81
Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis. J Cardiovasc Pharmacol (2009) 0.81
Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications. Blood Coagul Fibrinolysis (2003) 0.80
Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study. Thromb Res (2011) 0.80
On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin. Blood Coagul Fibrinolysis (2003) 0.79
Wireless powered capsule endoscopy for colon diagnosis and treatment. Physiol Meas (2013) 0.79
Leukocyte-derived microparticles and scanning electron microscopic structures in two fractions of fresh cerebrospinal fluid in amyotrophic lateral sclerosis: a case report. J Med Case Rep (2012) 0.79
Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study. Biochem Biophys Res Commun (2012) 0.79
Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease. Blood Coagul Fibrinolysis (2016) 0.79
Clotting onset time may be a predictor of outcome in human brain injury: a pilot study. J Neurosurg Anesthesiol (2003) 0.78
Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome. Platelets (2014) 0.78
Is fibrin formation and thrombin generation increased during and after an acute coronary syndrome? Thromb Res (2011) 0.78
CD40L expression in plasma of volunteers following LPS administration: A comparison between assay of CD40L on platelet microvesicles and soluble CD40L. Platelets (2014) 0.78
Tip-Directed Synthesis of Multimetallic Nanoparticles. J Am Chem Soc (2015) 0.77
Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia. Thromb Haemost (2009) 0.77
Conditioning of sewage sludge by Fenton's reagent combined with skeleton builders. Chemosphere (2012) 0.77
OWL-based nanomasks for preparing graphene ribbons with sub-10 nm gaps. Nano Lett (2012) 0.77
Microparticles and microscopic structures in three fractions of fresh cerebrospinal fluid in schizophrenia: case report of twins. Schizophr Res (2012) 0.77
Identifying hypocoagulable states with a modified global assay of overall haemostasis potential in plasma. Blood Coagul Fibrinolysis (2005) 0.77
Are results of fibrinogen measurements transferable? Clin Chem Lab Med (2003) 0.76
Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis. Thromb Res (2011) 0.76
ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus. Blood Coagul Fibrinolysis (2009) 0.76
Platelet activation during exercise is not attenuated by inhibition of the renin angiotensin system: the role of physical activity. J Hypertens (2013) 0.76
Comparison of venous and arterial blood sampling for the assessment of platelet aggregation with whole blood impedance aggregometry. Scand J Clin Lab Invest (2011) 0.75
Fibrin clot properties and haemostatic function in men and women with type 1 diabetes. Thromb Haemost (2014) 0.75
Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply. J Hypertens (2013) 0.75
Effects of vaginally administered high estradiol doses on hormonal pharmacokinetics and hemostasis in postmenopausal women. Fertil Steril (2002) 0.75
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation. Thromb Res (2002) 0.75
Application of a new method of revealing foramen ovale under X-ray in radiofrequency ablation in the treatment of trigeminal neuralgia. Br J Neurosurg (2011) 0.75
[Relationship of evaluation indexes of sludge dewatering performance under different conditioning programs]. Huan Jing Ke Xue (2011) 0.75
Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger. Thromb Haemost (2014) 0.75
Clinical value of a self-designed training model for pinpointing and puncturing trigeminal ganglion. Br J Neurosurg (2013) 0.75
Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system. Thromb Haemost (2016) 0.75
[Influence of the Application of Activated Persulfate on Municipal Sludge Conditioning]. Huan Jing Ke Xue (2015) 0.75
[Chest pain in women with low risk of coronary disease. Think of coronary artery dissection]. Lakartidningen (2010) 0.75
A comprehensive insight into the combined effects of Fenton's reagent and skeleton builders on sludge deep dewatering performance. J Hazard Mater (2013) 0.75
A fibrinogen concentrate Haemocomplettan (Riastap) or a Factor XIII concentrate Fibrogammin combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor. Br J Haematol (2013) 0.75
Correlation of ECR1 A3650G polymorphism with neonatal respiratory distress syndrome. Genet Test Mol Biomarkers (2015) 0.75
Experimental research on anchoring force in intestine for the motion of capsule robot. J Med Eng Technol (2013) 0.75
In vitro assessment of platelet concentrates with multiple electrode aggregometry. Platelets (2014) 0.75
Bedside monitoring of coagulation activation after challenging healthy volunteers with intravenous endotoxin. Thromb Res (2003) 0.75
A feasibility study on pinpointing the branches of trigeminal nerve in radiofrequency ablation. Br J Neurosurg (2012) 0.75